OwlTail

Cover image of Sawsan Youssef

Sawsan Youssef

2 Podcast Episodes

Latest 5 Jun 2021 | Updated Daily

Weekly hand curated podcast episodes for learning

Episode artwork

Immuno-Engineering the Future of Wellness—Sawsan Youssef—Chief Scientific Officer at Distributed Bio

Finding Genius Podcast

Chief Scientific Officer at Distributed Bio, Sawsan Youssef, joins the show to discuss her work at this unique company, and why it might hold promise for treating the COVID-19 virus and other medical conditions. In this episode, you will learn: What an antibody is, and how antibody therapeutics are developed How antibody therapy might prevent the COVID-19 virus from binding to host cells, thereby preventing illness How Distributed Bio identifies which antibodies will provide the most optimal binding properties at optimal binding sites for a given virus or disease Distributed Bio is a small, self-funded biotechnology company that’s creating new technologies for therapeutics in a variety of medical fields by using immunology as the platform. There are two type of therapeutics in their current portfolio: one that relies on antibody generation, and one that is vaccine-based. In response to the COVID-19 pandemic, Distributed Bio is developing a therapeutic which is based on the use of antibodies. Youssef explains the science and biology behind how antibody therapy works and why the use of antibodies to combat viruses is not only effective, but less likely to cause dangerous side effects. Generally speaking, antibodies are a good type of therapeutic because they are well-tolerated by the body and target precisely what you’re aiming for. In contrast, the use of other small molecules in therapeutics might target what you’re aiming for, but they may also target multiple other pathways in the body along the way, leading to adverse effects. Youssef discusses a number of other important topics, including how this technology could treat autoimmune diseases like lupus, the role of antibody therapeutics in the field of oncology, in what ways some viruses are able to render binding antibodies ineffective, and the timeframe on the COVID-19 therapeutic that’s in the works. Press play for all the details, and learn more about these technologies at https://www.distributedbio.com/. Available on Apple Podcasts: apple.co/2Os0myK

37mins

7 Jul 2020

Episode artwork

From Israel to Immunologist w/ Sawsan Youssef

The Apex Podcast

In this episode, Jan and RJ interview Distributed Bio’s Chief Science Officer and Immunologist Sawsan Youssef. They discuss her journey from Israel to Stanford and beyond. From couch surfing when she first arrived in the US, to being a renowned immunologist working on treatments for everything from Cancer to MS. She is now part of a team that is working non-stop to fight the battle against COVID-19 testing billions of modified SARS antibodies in an effort to identify a treatment for COVID-19. - Check out Distributed Bio Here: https://www.distributedbio.com/ - If you want to support us, there are three ways to do so. One is to donate to the cause at www.patreon.com/theapexpodcast! Even a small donation of a DOLLAR a month opens up access to all of the up and coming Patreon based content and a FIVE dollar donation earns you a live THANK YOU from Jan and RJ live on an episode of The Apex! Second, visit our merch line that is proudly partnered with Envision Clothing Company... https://envisionclothingcompany.com/collections/the-apex-chasers The final one is completely FREE. All we ask is if you learned something from this episode or know of someone that needs to hear our message. Share it with them! Follow us on social media: Twitter (Jan): @_theapexpodcast Twitter (RJ): @docholliday92 Instagram: @_TheApexPodcast_ Website: https://www.theapexpodcast.com Know someone who would be a good guest? Email our producer Jacob Popio at Jacob@chasetheapex.com

1hr 5mins

25 Mar 2020

Similar People